Gene.iO 2023 – 8 award-winning innovative biotechs
October 16, 2023 – 8 innovative biotech companies have just been selected in the 3rd promotion of Genopole's Gene.iO program: they win a year's coaching at the cutting edge of biotech expertise, to help them successfully raise their first funds or sign their first commercial agreement.
16 October 0203
Read the article
Genopole announces 5 i-Lab startup winners
July 6, 2023 – Five biotech companies from Genopole, a biocluster dedicated to innovation for health and sustainable development, have won the i-Lab national competition run by Bpifrance and the French Ministry of Higher Education, Research and Innovation, to support the most promising deep-tech companies in France.
06 July 2023
Read the article
Biopharmaceuticals Major Challenge: The University of Évry and Genopole present in three of the eight laureate projects
ART-TG, CiTHERA, I-Stem and Yposkesi are contributing their expertise to three projects named on 3 February 2022 as laureates for the French Government's Major Challenges program.
02 March 2022
Read the article
IGEM 2021: Yet another Gold Medal!
19 novembre 2021 – Pour la 5ème année consécutive, l’équipe d’Évry décroche une médaille d’or au célèbre concours international en biologie de synthèse iGEM, grâce à son projet « Evolution T7 » reposant sur l’évolution génétique dirigée et ouvrant un vaste champ d’applications.
19 November 2021
Read the article
Algentech: High-Yield Molecular Farming Of Industrial Ingredients In Plant Chloroplasts
22 juin 2021 – Algentech, a Genopole-accredited French company, has achieved a world's first with its disruptive technology . The company's patented method enables the production of proteins and nucleic acids in plant chloroplasts.
22 June 2021
Read the article
Genopole earns EU|BIC certification
5 décembre 2020 The European Commission's European Business Network (EBN) voted unanimously to certify Genopole as a European Union | Business and Innovation Center (EU|BIC), thus recognizing France's leading biocluster as a key contributor to R&D and Innovation in Genomics in France and Europe.
5 December 2020
Read the article
Enalees announces clinical trial for a COVID-19 test
16 septembre 2020 – C4Diagnostics, Bertin Technologies and Enalees announced the launch of a prospective clinical trial for BEC-SARS-CoV-2 for humans, a rapid, point-of-care diagnostic for COVID-19.
16 September 2020
Read the article
Ÿnsect obtains market approval for an insect-based fertilizer
17 juin 2020 – Ÿnsect has just gained approval for its natural insect fertilizer “ŸnFrass” issued by ANSES, the French Agency for Food, Environmental and Occupational Health & Safety. Ÿnsect thus becomes the first company in the world to obtain certification and marketing approval for a natural insect-based fertilizer.
17 June 2020
Read the article
Pharnext – A novel strategy to rapidly reposition drugs using existing COVID-19 clinical data
23 mars 2020 – Pharnext annonce l’identification de 97 médicaments fréquemment prescrits, au moyen de sa plateforme de Pleotherapy, comme candidats potentiels au repositionnement dans le traitement du COVID-19.
23 March 2020
Read the article
A Friendly Takeover Bid Initiated by OncoDNA on IntegraGen
July 09, 2020 This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.
9 July 2020
Read the article
IntegraGen renews its agreement with the Institut Pasteur
11 mars 2020 – IntegraGen announces the renewal of its partnership agreement with the Institut Pasteur until December 2021 related to high-throughput sequencing operations for microbiology activities carried out at the Institut Pasteur
11 March 2020
Read the article
AB Science : masitinib’s potential mode of action in Alzheimer’s Disease
July 08, 2020 – AB Science SA announced the publication of preclinical study results with masitinib in Alzheimer’s disease entitled, ‘Effects of chronic masitinib treatment in APPPS1dE9 transgenic mice modeling Alzheimer’s disease’.
8 July 2020
Read the article
Algentech Granted US Patent For A Key Genome Editing Technology
16 janvier 2020- Algentech annonce la délivrance d'un brevet clé dans le domaine de l'édition du génome par l'Office des brevets des États-Unis
16 January 2020
Read the article
